This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Yuzhalin AE. Redefining cancer research for therapeutic breakthroughs. Br J Cancer. 2024;130:1078–82. https://doi.org/10.1038/s41416-024-02634-6.
Zang Y, Lee JJ. Adaptive clinical trial designs in oncology. Chin Clin Oncol. 2014;3:49. https://doi.org/10.3978/j.issn.2304-3865.2014.06.04.
Mullins CD, Vandigo J, Zheng Z, Wicks P. Patient-centeredness in the design of clinical trials. Value Health. 2014;17:471–5. https://doi.org/10.1016/j.jval.2014.02.012.
Pallmann P, Bedding AW, Choodari-Oskooei B, Dimairo M, Flight L, Hampson LV, et al. Adaptive designs in clinical trials: why use them, and how to run and report them. BMC Med. 2018;16:29. https://doi.org/10.1186/s12916-018-1017-7.
Mehrara E, Forssell-Aronsson E, Bernhardt P. Objective assessment of tumour response to therapy based on tumour growth kinetics. Br J Cancer. 2011;105:682–6. https://doi.org/10.1038/bjc.2011.276.
Kim ES, Atlas J, Ison G, Ersek JL. Transforming Clinical Trial Eligibility Criteria to Reflect Practical Clinical Application. Am Soc Clin Oncol Educ Book. 2016;35:83–90. https://doi.org/10.1200/EDBK_155880.
Johnson K, Gomez A, Burton J, White D, Chakravarty A, Schmid A, et al. Directional inconsistency between Response Evaluation Criteria in Solid Tumors (RECIST) time to progression and response speed and depth. Eur J Cancer. 2019;109:196–203. https://doi.org/10.1016/j.ejca.2018.11.008.
Xie X, Li X, Yao W. A narrative review: depth of response as a predictor of the long-term outcomes for solid tumors. Transl Cancer Res. 2021;10:1119–30. https://doi.org/10.21037/tcr-20-2547.
Tang M, Pearson SA, Simes RJ, Chua BH. Harnessing Real-World Evidence to Advance Cancer Research. Curr Oncol. 2023;30:1844–59. https://doi.org/10.3390/curroncol30020143.
Farah E, Kenney M, Kica A, Haddad P, Stewart DJ, Bradford JP. Beyond Participation: Evaluating the Role of Patients in Designing Oncology Clinical Trials. Curr Oncol. 2023;30:8310–27. https://doi.org/10.3390/curroncol30090603.
Author information
Authors and Affiliations
Contributions
All contributions to this article its from Dr. Prasad Cooray (single author).
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cooray, P. Comment on “Redefining cancer research for therapeutic breakthroughs”. Br J Cancer (2024). https://doi.org/10.1038/s41416-024-02695-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41416-024-02695-7